Cangene (FRA:YGE) Revenue : €87.29 Mil (TTM As of Oct. 2013)

Cangene Revenue Chart

Cangene Annual Data
	Trend	Jul04	Jul05	Jul06	Jul07	Jul08	Jul09	Jul10	Jul11	Jul12	Jul13
Revenue		Get a 7-Day Free Trial					157.46	117.52	104.95	90.38	97.27

Cangene Quarterly Data
	Jan09	Apr09	Jul09	Oct09	Jan10	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13
Revenue	Get a 7-Day Free Trial															28.13	19.49	30.91	18.85	18.04

Competitive Comparison of Cangene's Revenue

For the Biotechnology subindustry, Cangene's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cangene's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's Revenue distribution charts can be found below:

* The bar in red indicates where Cangene's Revenue falls into.

Cangene Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Oct. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was €87.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cangene  (FRA:YGE) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Cangene Revenue Related Terms

Thank you for viewing the detailed overview of Cangene's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cangene (FRA:YGE) Business Description